Literature DB >> 2827329

Surgical approaches for unresectable primary carcinoma of the hepatic hilus.

N J Lygidakis1, M N van der Heyde, R J van Dongen, J G Kromhout, G N Tytgat, K Huibregtse.   

Abstract

Thirteen patients with proximal malignant obstruction of the biliary tract secondary to primary cholangiocarcinoma are presented. Seven of these patients had bilateral involvement of the major vessels of the porta hepatis, and 12 had bilateral involvement of the main hepatic ducts up to the level of segmental bifurcation. Resection of the tumor was carried out in all of the patients. Extensive resection of the liver with resection of the regional vascular structures was done in six. Another six underwent resection of the liver without resection of the regional vascular structures. The remaining patient underwent resection of the tumor and of the regional revascular structures alone. Vascular resection included resection and reconstruction of both the portal vein and hepatic artery in four patients or only of the portal vein in three. Biliary drainage was carried out by intrahepatic cholangiojejunostomies between segmental hepatic ducts and a Roux-en-Y loop. Two patients died and ten are alive. The quality of postoperative life is satisfactory and the patients are free of sequelae and symptoms secondary to operation or disease. This approach is recommended for the management of a number of patients with bilateral vascular or biliary involvement secondary to primary cholangiocarcinoma of the porta hepatis. For those patients, this approach offers a promising alternative.

Entities:  

Mesh:

Year:  1988        PMID: 2827329

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  9 in total

1.  Partial portal arterialization for the prevention of massive liver necrosis following extended pancreatobiliary surgery: experience of two cases.

Authors:  J Iseki; K Touyama; T Noie; K Nakagami; M Takagi; K Hakamada; A Tanaka; A Yamada; J Hanakita; H Suwa
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

Review 2.  Systematic review and meta-analysis of the role of vascular resection in the treatment of hilar cholangiocarcinoma.

Authors:  Saleh Abbas; Charbel Sandroussi
Journal:  HPB (Oxford)       Date:  2013-01-08       Impact factor: 3.647

3.  Successful management of portal hypertension following artificial arterioportal shunting: report of a case.

Authors:  S Ko; Y Nakajima; H Kanehiro; Y Aomatsu; A Yoshimura; J Taki; M Ueno; T Kin; H Nakano
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

4.  Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases.

Authors:  J R Madariaga; S Iwatsuki; S Todo; R G Lee; W Irish; T E Starzl
Journal:  Ann Surg       Date:  1998-01       Impact factor: 12.969

Review 5.  Surgical treatment in proximal bile duct cancer. A single-center experience.

Authors:  R Pichlmayr; A Weimann; J Klempnauer; K J Oldhafer; H Maschek; G Tusch; B Ringe
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

6.  Value of Multidetector-row Computed Tomography in Diagnosis of Portal Vein Invasion by Perihilar Cholangiocarcinoma.

Authors:  Teiichi Sugiura; Hideki Nishio; Masato Nagino; Yoshiki Senda; Tomoki Ebata; Yukihiro Yokoyama; Tsuyoshi Igami; Koji Oda; Yuji Nimura
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

7.  Hepatic resection combined with portal vein or hepatic artery reconstruction for advanced carcinoma of the hilar bile duct and gallbladder.

Authors:  Hiroshi Shimada; Itaru Endo; Mitsutaka Sugita; Hideki Masunari; Yoshiro Fujii; Kuniya Tanaka; Koichi Misuta; Hitoshi Sekido; Shinji Togo
Journal:  World J Surg       Date:  2003-08-21       Impact factor: 3.352

8.  Role of nodal involvement and the periductal soft-tissue margin in middle and distal bile duct cancer.

Authors:  M Kayahara; T Nagakawa; T Ohta; H Kitagawa; H Tajima; K Miwa
Journal:  Ann Surg       Date:  1999-01       Impact factor: 12.969

9.  Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma.

Authors:  C H Su; S H Tsay; C C Wu; Y M Shyr; K L King; C H Lee; W Y Lui; T J Liu; F K P'eng
Journal:  Ann Surg       Date:  1996-04       Impact factor: 12.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.